Bridgewater Systems Agrees to Sale to Amdocs
Bridgewater Systems, which is backed by VenGrowth Asset Management, has agreed to be sold to Amdocs Ltd. Amdocs is paying C$8.20 a share cash, valuing Bridgewater at C$211million. Amdocs had previously announced the acquisition earlier this month.
Bridgewater Systems Agrees to Sale to Amdocs
Bridgewater Systems, which is backed by VenGrowth Asset Management, has agreed to be sold to Amdocs Ltd. Amdocs is paying C$8.20 a share cash, valuing Bridgewater at C$211million. Amdocs had previously announced the acquisition earlier this month.
The Bond Herd, 6% and Gold
The Bond Herd, 6% and Gold December 16, 2010 Europe is very cold, too. We’re back. Six days of travel, 8000 miles, and seven meetings later, we take away some conclusions about the recent, volatile, and scary spike in bond yields. First and foremost, let’s be clear. This bond market riot is a global phenomenon....
Endologix Buys Venture-backed Nellix
Publicly traded Endologix has acquired venture-backed medical device company Nellix Endovascular for $15 million in stock, plus additional milestone-based stock payments totaling as much as $39 million. As part of the acquisition, Nellix’s majority investor, Essex Woodlands Health Ventures, will also invest $15 million in the newly combined company. Palo Alto, Calif.-based Essex Woodlands Health...
The Irish Bank Bailout and Spain’s Downgrade
Filed under: Economic Data, Financial CrisisJust when fears of a eurozone collapse faded from the front page, the news of an Irish bank bailout and of Spain's credit rating downgrade reignited investor concerns, CNN Money reports.
Ireland's central ba...
The Confidence Game: a commentary on the Ackman-MBIA book
A correction to this post re the Australian infrastructure projects is at the end...The Confidence Game – the book about Bill Ackman’s pursuit of MBIA is a good book – but this post is not a review – rather a commentary ex-post on the whole bo...
TriVascular2 Raises $30 Million
TriVascular, a Santa Rosa, Calif.-based developer of endovascular repair devices for treating abdominal aortic aneurysms, has raised $30 million in Series B funding. Return backers include New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners. The company previously raised $65 million, part of which was used to purchase TriVascular from Boston Scientific (which...
